Funder: National Institutes of Health

Due Dates: May 28, 2025 | September 29, 2025 | January 28, 2026 | May 28, 2026 | September 28, 2026 | January 28, 2027 | May 28, 2027 | September 28, 2027

Funding Amounts: Direct costs per year: $2.6M–$6.5M (tiered by institutional NIH funding); up to 7 years per award; pilot projects: $25K–$50K each; CTS Research Program: up to $500K/year.

Summary: Supports CTSA Program hubs to accelerate clinical and translational science, foster innovation, partnerships, and workforce development, and rapidly address public health needs.

Key Information: Requires concurrent K12 application; clinical trial support limited to phase IIB (except rare disease phase III); non-domestic organizations not eligible to apply.